Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness involves hormones and cell signals affecting hair growth.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Testosterone may slow down wound healing and increase inflammation.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Finasteride helps treat hair loss by blocking enzyme activity.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.